Apex Fundrock Limited (MISL) Form 8.3 - Apex Fundrock Limited : Re Equals Group plc 07-May-2024 / 13:34 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Chelverton Asset Management (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the truste...
Shapeways Announces Definitive Agreement to Sell Software Assets NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Shapeways Holdings, Inc. (NASDAQ: SHPW) (“Shapeways” or the “Company”), a leader in the large and fast-growing digital manufacturing industry, today announced that it has entered into an asset purchase agreement in connection with the sale of its software business to OTTO dms, Inc., an entity wholly-owned by Shapeways’ Chief Executive Officer, Greg Kress and the Executive of Shapeways’ software business unit, Greg Rothman. As previously disclosed, the Company has been working with ...
A director at Wilmar International Limited bought 7,954,200 shares at 3.229SGD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
A director at Synthesis Electronic Technology Co Ltd bought 20,000 shares at 16.300CNY and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...
A director at Jiangsu Jinling Sports Equipment Co Ltd bought 150,000 shares at 14.050CNY and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...
A director at Carsgen Therapeutics Holdings Limited bought 815,000 shares at 5.930HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...
A director at Boltek Holdings Limited maiden bought 3,960,000 shares at 0.300HKD and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
A director at NSI NV bought 1,000 shares at 18.100EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...
EQS-News: Wienerberger AG / Key word(s): AGM/EGM 155th wienerberger Annual General Meeting: All resolutions adopted 07.05.2024 / 14:30 CET/CEST The issuer is solely responsible for the content of this announcement. 155th wienerberger Annual General Meeting: All resolutions adopted Dividend of € 0.90 per share Heimo Scheuch, Chairman of the Managing Board of Wienerberger AG: “Perfectly positioned for further growth” Vienna, May 7, 2024 – The 155th Annual General Meeting of Wienerberger AG was held as an on-site meeting at Wiener Stadthalle on May 7, 2024. After the prese...
EQS-News: Wienerberger AG / Schlagwort(e): Hauptversammlung 155. ordentliche wienerberger Hauptversammlung: Alle Anträge genehmigt 07.05.2024 / 14:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 155. ordentliche wienerberger Hauptversammlung: Alle Anträge genehmigt Dividende von 0,90 € je Aktie Heimo Scheuch, Vorstandsvorsitzender der Wienerberger AG: „Bestens positioniert, um Wachstum weiter voranzutreiben“ Wien, 07. Mai 2024 – Die 155. ordentliche Hauptversammlung der Wienerberger AG fand am 7. Mai 2024 als Präsenzveranstaltun...
Alliance Entertainment Announces Largest Sales Month for Independent Retail Division Coinciding with 2024 Record Store Day Event 2024 Record Store Day Shatters Previous Year’s Sales, Driven by Superstar Artists Releases PLANTATION, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Alliance Entertainment Holding Corporation (Nasdaq: ), a global distributor and wholesaler specializing in music, movies, video games, electronics, arcades, toys, and collectibles, today announced results of last month’s Record Store Day events. Record Store Day () is an annual event inaugurated in 2007 and held on one S...
Global Water Resources to Acquire Seven Water Systems from Tucson Water, Adding 2,200 Customer Connections PHOENIX, May 07, 2024 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, has entered into an agreement to acquire seven water systems from the City of Tucson’s water utility. The systems are located in and around Pima County where they serve approximately 2,200 customers. Following their acquisition, they would be integrated with existing Global Water utilities in the area. The addition of the new systems wi...
Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights - Interim data from SEAPORT-1, a Phase 1 trial of INZ-701 in patients with end-stage kidney disease receiving hemodialysis, on track for fourth quarter of 2024 - - Interim data from ENERGY-1, a Phase 1b trial of INZ-701 in infants with ENPP1 Deficiency, on track for second half of 2024 - - Cash, cash equivalents, and short-term investments as of March 31, 2024, expected to fund operations into the fourth quarter of 2025 - BOSTON, May 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: INZY) (“the Company”...
Global Ship Lease Announces First Quarter 2024 Earnings Release, Conference Call and Webcast ATHENS, Greece, May 07, 2024 (GLOBE NEWSWIRE) -- Global Ship Lease, Inc. (NYSE:GSL) (the “Company”), a containership charter owner, announced today that it will hold a conference call to discuss the Company’s results for the first quarter 2024 on Thursday, May 16, 2024 at 10:30 a.m. Eastern Time. The Company will issue financial results for the first quarter 2024 on Thursday, May 16, 2024, before the open of market trading. What:First Quarter 2024 Conference Call and Webcast When:Thursday, May 16...
Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024 Company to host conference call to discuss financial results and provide a corporate update on May 13, 2024 at 4:30 p.m. ET SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced the Company will release its first quarter...
A director at Jiangsu Tongli Risheng Machinery Co Ltd bought 465,100 shares at 21.760CNY and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...
Two Directors at Rotshtein Realestate Ltd sold/bought/maiden bought 480,948 shares at 36.100ILS. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...
Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference CAMBRIDGE, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference in New York City on Tuesday, May 14, 2024, at 8:30 a.m. ET. A live webcast of this presenta...
Palisade Bio Appoints Margery Fischbein to its Board of Directors Wall Street and biotech industry veteran with expertise across corporate finance, business development, M&A, licensing, and strategic alliance transactions, globally Carlsbad, CA, May 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: PALI) (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced it has appointed Margery Fischbein to its Board of Directors. Ms...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.